BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States. It operates in two segments, Maintenance Services and Development Services. The Maintenance Services segment delivers a suite of recurring commercial landscaping services, including mowing, gardening, mulching and snow removal, water management, irrigation maintenance, tree care, golf course maintenance, and specialty turf maintenance. Its customers' properties include corporate and commercial properties, homeowners associations, public parks, hotels and resorts, airport authorities, municipalities, hospitals and other healthcare facilities, educational institutions, restaurants and retail, and golf courses. This segment's customer base includes approximately 11,700 office parks and corporate campuses 10,000 residential communities, and 700 educational institutions. The Development Services segment offers landscape architecture and development services for new facilities and redesign projects. Its services include project design and management services, landscape architecture and installation, irrigation installation, tree moving and installation, pool and water features, sports field, and other services. BrightView Holdings, Inc. also operates as official field consultant to Major League Baseball. The company was formerly known as BrightView Acquisition Holdings, Inc. BrightView Holdings, Inc. was founded in 1939 and is headquartered in Blue Bell, Pennsylvania.

BrightView Holdings, Inc.

Abivax SA ( ($FR:ABVX) ) has shared an update. Abivax reported that, as of August 31, 2026, its share capital consists of 87,271,525 shares, corres...

Abivax Updates Share Capital and Voting Rights Structure as of August 31, 2026

In a report released today, Glynis Johnson from Jefferies reiterated a Hold rating on Vistry Group, with a price target of p274.00. Johnson covers ...

Vistry Group (VTY) Gets a Hold from Jefferies

Deutsche Bank analyst Alfredo Alonso Estudillo maintained a Hold rating on Banco Bilbao Vizcaya Argentaria today and set a price target of €23.65. ...

Banco Bilbao Vizcaya Argentaria (BVA) Receives a Rating Update from a Top Analyst

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has provided an update. Trading in Bulbuloglu Vinc Sanayi ve Ticaret A.S. shares on Borsa Is...

Bulbuloglu Vinc Shares Enter Circuit Breaker Call Auction on Borsa Istanbul

Bellavista Resources Ltd ( ($AU:BVR) ) just unveiled an update. Bellavista Resources has scheduled its Annual General Meeting for Monday, 23 Novemb...

Bellavista sets AGM date and deadline for director nominations

In a report released on September 21, Trung Huynh from RBC Capital maintained a Buy rating on AbbVie, with a price target of $280.00. The company’s...

RBC Capital Sticks to Its Buy Rating for AbbVie (ABBV)

Thai Beverage Public Co ( ($SG:Y92) ) has shared an update. ThaiBev has approved a wide-ranging reorganization of its corporate structure and execu...

ThaiBev Reshapes Executive Structure to Drive PASSION 2030 Growth

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on PWR Holdings (PWRHF) and Breville Group (BVIL...

Analysts Are Bullish on Top Consumer Cyclical Stocks: PWR Holdings (PWRHF), Breville Group (BVILF)

An announcement from Itau Unibanco ( ($ITUB) ) is now available. Itaú Unibanco announced that its chief executive, Milton Maluhy Filho, will partic...

Itaú Unibanco to Present Strategy Outlook at Itaúsa’s Panorama 2026 Event

An update from BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) is now available. Trading in Bulbuloğlu Vinc Sanayi ve Ticaret A.Ş. shares un...

Circuit Breaker Triggers Auction Phase for Bulbuloğlu Vinc Shares

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abivax SA Sponsored ADR (ABVX) and Biodesix (BDSX) w...

Analysts’ Top Healthcare Picks: Abivax SA Sponsored ADR (ABVX), Biodesix (BDSX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DBV Technologies SA – American (DBVT) and TransMedic...

Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abivax SA Sponsored ADR (ABVX) and Siemens Healthine...

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)

CEO Event Medya AS ( ($TR:CEOEM) ) has issued an update. Turkey’s Central Securities Depository (MKK) has published a detailed breakdown of changes...

MKK Disclosure Reveals Major Shifts in Shareholdings Across Borsa Istanbul

Abivax SA ( ($FR:ABVX) ) has issued an announcement. Abivax has overhauled its leadership team as it prepares for potential commercialization of ob...

Abivax bolsters leadership and balance sheet as obefazimod nears commercialization

ADARx Pharmaceuticals, which is using RNA technology to fight diseases like Alzheimer’s, is targeting a valuation of up to $1.74 billion in its U.S...

Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO

In a report released yesterday, Miruna Chirea from Jefferies maintained a Buy rating on Banco Bilbao Vizcaya Argentaria. The company’s shares close...

Jefferies Reaffirms Their Buy Rating on Banco Bilbao Vizcaya Argentaria (BVA)

Abivax ($ABVX) stock was down 2.43% on Friday ahead of the French pharmaceutical company’s upcoming earnings report. The company is set to release ...

Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings?

Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ) has provided an update. Hub Girişim Sermayesi Yatırım Ortaklığı A.Ş. announced a leade...

Hub Girişim Sermayesi Yatırım Ortaklığı Appoints New Chairman After Board Resignation

In a report released today, Anthony Codling from RBC Capital maintained a Sell rating on Vistry Group, with a price target of p180.00. According to...

Vistry Group (VTY) Gets a Sell from RBC Capital

Bellavista Resources Ltd ( ($AU:BVR) ) has provided an update. Bellavista Resources has reported progress on its Pickle Crow gold project in Ontari...

Bellavista Advances Canadian and Australian Projects Amid Drilling and Testwork

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest dry eye study compares its new ABBV-444 artificial tear against...

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

An update from BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) is now available. Bank of America Corporation, through its wholly controlled ...

Bank of America Lifts Stake in Bülbüloğlu Vinç to Just Over 3%

Vistry Group ( ($GB:VTY) ) has issued an update. Vistry Group PLC disclosed a routine share transaction involving Executive Chair Daniel King under...

Vistry Executive Chair Adds Shares Through Incentive Plan

The latest announcement is out from BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ). Trading in BULBULOGLU VINC SANAYI VE TICARET A.S. share...

Circuit Breaker Triggers Call Auction in BULBULOGLU VINC Shares

Baronsmead Venture ( ($GB:BVT) ) has issued an announcement. Baronsmead Venture Trust PLC, a UK venture capital trust investing in smaller growth c...

Baronsmead Venture Trust Adjusts Treasury Shareholdings and Voting Rights

Top Glove Bhd ( ($TPGVF) ) just unveiled an announcement. Top Glove Corporation Bhd disclosed a change in the interest of a substantial shareholder...

Top Glove Announces Share Disposal by Major Pension Fund Shareholder

RBC Capital analyst Trung Huynh maintained a Buy rating on AbbVie yesterday and set a price target of $280.00. According to TipRanks, Huynh is a 5-...

RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)

An announcement from Top Glove Bhd ( ($TPGVF) ) is now available. Malaysian pension fund Kumpulan Wang Persaraan (Diperbadankan) has adjusted its s...

KWAP Adjusts Substantial Shareholding in Top Glove

Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ) has issued an update. Trading in HUBVC.E has been temporarily halted under an equity-b...

Circuit Breaker Halts HUBVC.E, Trading to Resume via Call Auction

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has provided an update. Borsa Istanbul has temporarily suspended continuous trading in BVSAN...

Borsa Istanbul Triggers Circuit Breaker in BVSAN Shares

The latest announcement is out from Kaplamin Ambalaj Sanayi ve Ticaret A.S. ( ($TR:KAPLM) ). A disclosure filed via the Turkish Public Disclosure P...

Institutional investors adjust stakes in Kaplamin Ambalaj and peers

Abbvie ($ABBV) announced an update on their ongoing clinical study. The AbbVie Inc. (ABBV) ECLIPSE study, officially titled “Randomized, Double-bli...

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

Itau Unibanco ( ($ITUB) ) has provided an announcement. On September 10, 2026, Itaú Unibanco issued R$5 billion in Tier 2 subordinated financial bi...

Itaú Unibanco Boosts Capital With R$5 Billion Tier 2 Subordinated Issue

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC) and AbbVie (ABBV) with bullish sentiment...

Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and AbbVie (ABBV)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adagene (ADAG), AbbVie (ABBV) and Definium Therapeut...

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbbVie (ABBV) and Pyxis Oncology (PYXS) with bullish...

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Pyxis Oncology (PYXS)

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is reporting new data from an observational eye study in adults with dia...

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

Bulbuloglu Vinc Shares Shift to Call Auction Under Borsa Istanbul Circuit Breaker

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) just unveiled an announcement. Bulbuloglu Vinc Sanayi ve Ticaret A.S. saw a significant tran...

Bulbuloglu Vinc Shares See Large Block Trade on Borsa Istanbul Main Market

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has shared an announcement. Shareholder Önder Bülbüloğlu is divesting a stake with a nominal...

Bülbüloğlu Vinç Shareholder Sells 3% Stake in Wholesale Borsa Istanbul Deal

RedHill Biopharma ($RHDL) has said the acquisition from Ferring of commercialization rights to two established gastrointestinal (GI) FDA-approved d...

RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio

Baronsmead Venture ( ($GB:BVT) ) has provided an update. Baronsmead Venture Trust PLC has released its quarterly factsheet for the three months end...

Baronsmead Venture Trust Publishes Q2 2026 Factsheet for Investors

An announcement from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) is now available. BBVA has provided an update on the execution of the first tra...

BBVA Advances First Tranche of Share Buyback Program, Deploys 59% of Allocated Funds

Bravura Solutions Limited ( ($AU:BVS) ) just unveiled an announcement. Bravura Solutions Limited has appointed Ian Whiting as a director effective ...

Bravura Solutions Adds New Director With No Current Equity Stake

Bravura Solutions Limited ( ($AU:BVS) ) has provided an announcement. Bravura Solutions has strengthened its board by appointing Ian Whiting as an ...

Bravura adds global software veteran to board as two directors signal 2026 exit

Migros Ticaret A.S. ( ($TR:MGROS) ) has provided an announcement. Migros Ticaret A.Ş. and Bülbüloğlu Vinç Sanayi ve Ticaret A.Ş. have disclosed to ...

Migros and Bülbüloğlu Vinç Shares Set to Convert Into Tradable Stock

Tera Yatirim Menkul Degerler AS ( ($TR:TERA) ) just unveiled an announcement. Tera Yatirim Menkul Degerler AS has applied to Borsa İstanbul to exec...

Tera Yatirim to Acquire 3% Bülbüloğlu Vinç Stake via Borsa İstanbul Wholesale Deal

The latest announcement is out from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ). BBVA has reported a significant event concerning its ongoing sh...

BBVA Publishes Periodic Report on Ongoing Share Buyback Program

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annovis Bio (ANVS), AbbVie (ABBV) and Glaukos (GKOS)...

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

An update from Baronsmead Venture ( ($GB:BVT) ) is now available. Baronsmead Venture Trust PLC, a UK venture capital trust investing in smaller and...

Baronsmead Venture Trust Plans Joint £10m Fundraising with Sister VCT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS...

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS) and AbbVie (ABBV)

Nubeva Technologies Ltd ( ($TSE:NBVA) ) just unveiled an announcement. Nubeva Technologies Ltd. has secured access to a frontier artificial intelli...

Nubeva Gains Access to Frontier AI Model for Ransomware Defense

The latest update is out from DBV Technologies ( ($FR:DBV) ). DBV Technologies will engage investors at three major healthcare and biopharma confer...

DBV Technologies Steps Up Investor Outreach Ahead of Key Food Allergy Trial Milestones

Claranova SA ( ($FR:ALCLA) ) has issued an update. Claranova SE has disclosed its share capital structure as of August 31, 2026, reporting 57,206,9...

Claranova Updates Market on Share Capital and Voting Rights Structure

Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ) has shared an announcement. Trading in HUBVC shares on Borsa Istanbul has been tempora...

HUBVC Trading Temporarily Shifted to Single-Price Auction After Circuit Breaker

Breville Group ( ($AU:BRG) ) just unveiled an update. Breville Group Limited has applied for quotation of 280,672 new ordinary fully paid shares on...

Breville Seeks ASX Quotation for 280,672 New Ordinary Shares

Breville Group ( ($AU:BRG) ) has provided an update. Breville Group Limited has applied to the ASX for quotation of 753,193 new fully paid ordinary...

Breville Seeks ASX Quotation for 753,193 New Ordinary Shares

DBV Technologies ( ($FR:DBV) ) has provided an update. DBV Technologies reported that its share capital comprised 314,388,807 shares as of August 3...

DBV Technologies Updates Share Capital and Voting Rights as of August 31, 2026

The latest announcement is out from Bureau Veritas ( ($FR:BVI) ). Bureau Veritas has completed a €700 million bond issuance with a 4.125% coupon, m...

Bureau Veritas Secures €700 Million Bond to Refinance Debt and Extend Maturities

The latest update is out from Bravura Solutions Limited ( ($AU:BVS) ). Bravura Solutions Limited has disclosed a late lodgement of an Appendix 3Y, ...

Bravura flags isolated late filing of director share change

The latest update is out from Nubeva Technologies Ltd ( ($TSE:NBVA) ). Nubeva Technologies Ltd., a ransomware-focused cybersecurity firm, has elect...

Nubeva Moves to Semi-Annual Reporting to Streamline Compliance

In a report released today, Rebecca Parker from Goldman Sachs maintained a Buy rating on Vistry Group, with a price target of p355.00. Parker cover...

Goldman Sachs Reaffirms Their Buy Rating on Vistry Group (VTY)

Banco Bilbao ( ($BBVA) ) just unveiled an announcement. BBVA has reported progress on the first tranche of its previously announced share buyback p...

BBVA Reaches Midpoint of First Tranche in € Share Buyback Program

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has issued an announcement. Bulbuloglu Vinc Sanayi ve Ticaret A.S., a crane manufacturing an...

Bulbuloglu Vinc Secures €1.06 Million Crane Contract with Sami Trafo

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is running a new Phase 2 platform basket study called “A Phase 2 ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BV	$10.41	+5.05%	1.48M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BV	$10.41	+5.0%	1.48M
3
4
5
6

BV

Get BrightView Holdings, Inc. Data in Excel

Get BrightView Holdings, Inc. Data in Excel